Free Trial
OTCMKTS:SZLSF

StageZero Life Sciences (SZLSF) Stock Price, News & Analysis

StageZero Life Sciences logo
$0.0030 0.00 (0.00%)
As of 05/22/2025 12:48 PM Eastern

About StageZero Life Sciences Stock (OTCMKTS:SZLSF)

Key Stats

Today's Range
$0.0030
$0.0030
50-Day Range
$0.00
$0.05
52-Week Range
$0.00
$1.00
Volume
3,000 shs
Average Volume
1,887 shs
Market Capitalization
$370,599.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.

Receive SZLSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

SZLSF Stock News Headlines

StageZero Life Sciences Ltd. (SZLSF)
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
Dually-Listed Healthcare Stock Rallies On Q1 Results
See More Headlines

SZLSF Stock Analysis - Frequently Asked Questions

StageZero Life Sciences' stock was trading at $0.0016 at the start of the year. Since then, SZLSF shares have increased by 87.5% and is now trading at $0.0030.
View the best growth stocks for 2025 here
.

Shares of SZLSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Diagnostic substances
Sub-Industry
N/A
Current Symbol
OTCMKTS:SZLSF
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.80 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
120,395,000
Market Cap
$370,599.00
Optionable
Not Optionable
Beta
-2.12
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:SZLSF) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners